TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean daily salivary cotinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of axial length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basic Life Support Competence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of the treatment of the odontogenic cyst
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with GERD post-op
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: HSP70 expression in tumor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Everyday Cognition questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Anxiety assessment - state anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety assessment - trait anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decongestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intestinal inflammation status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cognitive performance as measured by the Stroop Color and Word Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of Hemidiaphragmatic Paralysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage Change in Forced Expiratory Volume in 1 Second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage Change in Forced Vital Capacity (FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Successful application of Real-Time IGRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hospital bill
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Housing type
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Total perioperative complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) and/or dose range
Endpoint domain: Adverse events/effects
Primary endpoint: Peak Plantar Force (Forefoot)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plantar Force Impulse (Forefoot)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mMRC Dyspnea Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The COPD Assessment Test
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinical COPD Questionnaire (CCQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The Modified Borg Dyspnea Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Individual percent reduction in IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean reduction in intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Cause of admission of neonate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Dizziness Handicap Inventory (DHI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Dizziness Severity Evaluated by Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS visceral pain index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real-time self-reported pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS-quality of life (IBS-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Brachial Artery Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brachial Artery Mean Flow Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cervical joint position error test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidirectional reach test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dT-DNA Levels in Drainage Fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metacarpophalangeal joint flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Dose of postoperative nalbuphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amyotrophic Lateral Sclerosis Rating Scale (ALSFRS-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angiographic criteria success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: OCT criteria: Stent expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in glycemic variation by mean amplitude of glycemic excursion (MAGE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in inflammatory marker concentrations (sRAGE and hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Choroidal thickness measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications associated with prolonged CD4 T cell lymphopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Effect on upper urinary tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Safety of tamsulosin
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knowledge about HPV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge about HPV Vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: chemotherapy-associated peripheral neuropathic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: chemotherapy-associated peripheral neuropathic level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: cancer behaviour
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Number of Diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ventricular tachycardia (VT) episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of treatment-related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from Atrial Arrhythmia Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pressure gradient of venous return
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 30-day adverse aortic events
Endpoint domain: Adverse events/effects
Primary endpoint: Negative affective response to daily stressors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accelerated MRI Sequence Protocol Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified motor assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feedback questionnaires for patients, therapists and caretakers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in clinic systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: Change in depression symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: Percentage of Participants With Serious and Non-serious treatment-related TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With all serious TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With nonserious TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Pf blood-stage infection
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of the scalp cooling device
Endpoint domain: Adverse events/effects
Primary endpoint: Emotion Dysregulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sunny brook facial grading system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinovea Movement Analysis software
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter related bloodstream infection (CRBI) events
Endpoint domain: Adverse events/effects
Primary endpoint: Persistent Pulmonary Hypertension of the Newborn (PPHN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in weight-related experiential avoidance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood Pressure and Pulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: White Blood Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cmax for SY-5007
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax for SY-5007
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t for SY-5007
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Rating Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anger Parameters Scale (APS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anger Expressions Scale (AES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Monitored Anger (Anger Log)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Upper extremity range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient reported outcomes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Detection of KLF1 gene mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Shear wave dispersion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of target sample enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: percentage of adherence to ReadiWatch wear time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: percent attrition for the four teleCBT-I sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Composite complete remission rate (CRc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Minimum luminal area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Postoperative UDVA compared to preoperative CDVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of Residual Astigmatism postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative mean spherical equivalent MSE compared to Preoperative MSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day mRS score of 0 to 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time lag between diaphragmatic EMG signal and inspiratory flow zero crossing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dynamometer tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Variation of the NIPE measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from SAE/SADE
Endpoint domain: Adverse events/effects
Primary endpoint: rate of adenomatous polyps
Endpoint domain: Mortality/survival
Primary endpoint: rate of colorectal cancer
Endpoint domain: Mortality/survival
Primary endpoint: VerifyNow® PRUTest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VerifyNow® Aspirin Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of episodes
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in immunogenic response from baseline, Menveo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in immunogenic response from baseline, Bexsero
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in immunogenic response from baseline, Prevenar13/Pneumovax23
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number and percentage of treatment emergent adverse events (TEAE) and serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change from baseline in clinical laboratory values, vital signs, clinical findings from physical exam and ECG abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with AEH-free biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Therapeutic Response based on the Jankovic Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve From Time Zero to Time of the Last Measurable Concentration (AUClast) of BIIB091
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination Half-Life (t½) of BIIB091
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall preference of the patient
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confirmed Objective Response (OR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Profile From Time Zero to Extrapolated Infinite Time (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Profile From Time Zero to Last Quantifiable Concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with medically-attended adverse events following immunisation (AEFIs)
Endpoint domain: Adverse events/effects
Primary endpoint: ACR 20 response at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of the intraoperative surgical field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 50% prostate specific antigen (PSA) level reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Need for a Second Ultrasound-Guided Injection
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from Baseline Blood Pressure at 60 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pancreatic insulin production capacity (PIPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Airway blood flow reactivity (QAW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Police-reported motor vehicle crashes
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in LV function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in LV remodelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: GapCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in alignment of anterior teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Plaque Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Gum Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Count in S. Mutans Bacteria in Saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-in-serious hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time-in-range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Drug Abuse Screening Test (DAST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: natural history of prostate cancer with known germline and/or somatic variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: natural history of TMB-H prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Composite rate of 9 major adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with treatment emergent adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of participants with clinical laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic neurotransmitters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Biomarkers of metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change of body fat rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in requirement for oxygen supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in respiratory symptoms (cough, shortness of breath, and fatigue)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: VIDAS® TBI sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VIDAS® TBI specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VIDAS® TBI Positive Predictive Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DRM Task Performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: IL-17 Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RANKL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Growth and Development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Infection Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Mean change from baseline scores on the Arizona Phonological Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change from baseline scores on the naming task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change from baseline scores on the language probe task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fat Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Remembrance of pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in non-vellus target area hair count (TAHC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day functional prognosis
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Bone Ridge Width at Crest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Bone Ridge Width at 5mm Apical From Crest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Bone Ridge Width at 10mm Apical From Crest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Creatine kinase (CK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in squat jump height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal Clearance (CLr) of DC-806
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of DC-806 in Whole Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve (AUC) of DC-806 in Whole Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in social responsiveness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change from baseline Stereopsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes